| Literature DB >> 34136133 |
Igho J Onakpoya1, Carl J Heneghan1, Elizabeth A Spencer1, Jon Brassey2, Annette Plüddemann1, David H Evans3, John M Conly4, Tom Jefferson1.
Abstract
Background: SARS-CoV-2 has been detected in fomites which suggests the virus could be transmitted via inanimate objects. However, there is uncertainty about the mechanistic pathway for such transmissions. Our objective was to identify, appraise and summarise the evidence from primary studies and systematic reviews assessing the role of fomites in transmission.Entities:
Keywords: COVID-19; Fomites; systematic review; transmission
Year: 2021 PMID: 34136133 PMCID: PMC8176266 DOI: 10.12688/f1000research.51590.1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Figure 1. Flow diagram showing the process for inclusion of studies assessing fomites transmission in SARS-CoV-2.
Primary studies characteristics.
| Study ID
| Setting | Sources of fomites | Number of swab samples
| Viral
| Notes |
|---|---|---|---|---|---|
|
| Public places in urban area
| 15 bus stations, front-door sidewalk of 8
| 101 | No | Densely populated area. Ct<40
|
|
| 2 southern districts of
| Banknotes in circulation
| 850: both sides of each
| No | Circulating banknotes of varying
|
|
| 2 peri-urban informal
| Cistern handle, toilet seat, floor surface
| 68 | No | Sampling was done twice in September
|
|
| COVID-19 isolation units
|
| Smaller objects were
| Yes | Patients stayed in private rooms either
|
|
| Laboratory
| High-touch surfaces: Landline, barcode
| 22 | No | |
|
| Environmental surveillance
| Bench, bedside rail, locker, bed table,
| Not reported | No | Close contact referred to those with
|
|
| Hospital AIIRs in China
| Bed rail, locker, bed table, toilet door
| 377 | No | 21 patients. 12 air changes per hour.
|
|
| Hospital rooms of infected
| Floor, bedrail, locker handle, cardiac table,
| 245 | No | 12 air changes per hour. |
|
| Referral hospital in
| Buffer zone of patients' rooms: Door
| 16 | No | HCWs involved in the direct care of
|
|
| Infectious Disease
| Rooms of patients with CPAP helmet, room
| 26 | Yes | HCWs involved in the direct care of
|
|
| Acute COVID-19 ward of an
| Inside: Floor, bedside table, bathroom sink,
| 22 | No | Standard cleaning procedures twice
|
|
| COVID-19 non-Intensive
| Bed rail, sheets and pillow, floor and wall
| 24 | No | Sampling: 1st day - 18 hrs after
|
|
| The Second Hospital of
| Four isolation rooms, a nursing station, a
| 107 | No | 10 patients. A sample was defined as
|
|
| High-prevalence
| Electronic devices, Knobs and handles,
| 119 | Yes | Quarantined households. No
|
|
| Multipurpose ICU and a
| Door knob, chair telephone, computer
| 102 | No | All the ICU units were equipped with
|
|
| Frequently touched
|
| 202
| Yes |
|
|
| Isolated rural community
|
| 55 | No | |
|
| Hospital wards in 3
| Door handle, computer keyboard, nurses'
| 112 | No | The 3 hospitals with different protection
|
|
| Hospital Wards, Wuhan,
| Floors, computer mice, trash cans,
| 105 | No | |
|
| Public locations and
| High-touch nonporous surfaces likely to be
| 348 | No | Observed a total of 1815 people and 781
|
|
| Hospitals with COVID-19
| Cabinet, patient's bedrail, door handle and
| 24 | No | |
|
| Quarantine room,
| Corridor, bathroom, bedroom, living room
| 46 | No | All sites were sampled 3 times - 1st
|
|
| ED, ICU, HDU, 6 medical
| Patient room housing a laboratory-
| 81 | No | Timing of surface swab samples was
|
|
| 2 isolation areas at the
| Door handle, general surface, consulting
| 130 | No | 15 patients. |
|
| 2 rooms of a quarantine
| Door handle, light switch, faucet, bathroom
| 22 | No | 2 patients. Ct <40 was considered
|
|
| ICU in hospital, China
| Armrests on the patient’s bed, desk surface
| 5 | No | The ICU was routinely cleaned three
|
|
| Hospitalised patients with
| Bed rails, medical carts, the floor, door
| 220 | No | Medical staff used PPE and everyone
|
|
| 6 hospitals and 2 mass
| Frequently touched surfaces in wards
| 80 | No | Disinfection and cleaning had been
|
|
| ICU and an isolation ward
|
| 182 | No | Two samples collected in the morning.
|
|
| Hospital in Hong Kong | Disposable chopsticks | 14 | No | 5 consecutive asymptomatic and
|
|
| Laboratory, China, Feb and
| Door handle, elevator buttons, handles of
| 61 | No | |
|
| COVID-19 patients in ICU
|
| 242 | No | |
|
| 2 home-quarantined
| Floors, toilet door handle, AC filter, sink
| 22 | No | Home was naturally ventilated one
|
|
| 9 workplace locations in
| 24 high-frequency-touch point surfaces:
|
| No | Sampling occurred near the end of
|
|
| Hospitalised patient in
| Toilet door handle, door handle, nurse call
| 336 | Yes | 11 negative pressure isolation rooms.
|
|
| Hospitalised COVID-
| Ventilation exits, phones, tablets, masks,
| 141 | No | Environmental samples from all rooms
|
|
| Long-term care facilities
| High-touch surfaces, communal sites, and
| 89 | No | |
|
| ICU ward of hospital in
| Bedrail, floor, stethoscope, surgical
| 200 | Yes | Routine twice-daily environmental
|
|
| Dedicated SARS-CoV-2
| Infection isolation rooms (12 air exchanges
| 38 | No | One patient’s room was sampled
|
|
| HCWs caring for confirmed
| PPE | 90 | No | 15 patients. The median time spent by
|
|
| Single hospital room with
| Right bed rail, the call button, the bed
| 15 | No | Surfaces sampling was carried out two
|
|
| ED at a university hospital,
|
| 192 | Yes | Air exchange rate in the different rooms
|
|
| Hospital in Italy
| Indoor surfaces from three COVID-
| 92 | No | CT values ≤40 were considered positive. |
|
| COVID-19 ward of hospital
| Corridor for patients, ICU, undressing
| 37 | No | Negative airflow system. Sampling
|
|
| 2 different hospital settings
| Patient monitor, ventilator monitor, HFNC,
| No | No | Negative pressure rooms (A); 2
|
|
| Residential isolation rooms
| Personal items, remote controls, toilets,
| Non-specific (121 surface and
| Yes | Negative-pressure rooms (>12 ACH);
|
|
| Cross-sectional study
| Not specified | 10 | No | Surface disinfection was performed
|
|
| Chungbuk National
| Bedside table, bed rail, mobile phone,
| 12 | No | Mother and daughter who were COVID-
|
|
| Cross-sectional study
| Light switch, toilet seat, toilet floor, chair
| 601 | Yes | Median highest and lowest temperature
|
|
| Wuhan Leishenshan
| ICU, treatment room, laundry room,
| 62 | No | 7 COVID-19 patients. Negative pressure
|
|
| Isolation wards in the
| Isolation ICU ward and Isolation wards,
| 45 | Yes | 33 laboratory-confirmed COVID-19
|
|
| Dedicated isolation
| High-touch areas in the patient's
| 445 | No | 28 patients. Sterile premoistened swab
|
|
| Non-ICU rooms in a
| Bedrails, room and toilet door handles,
| 112 | No | 10 COVID-positive patients. Negative
|
|
| Non-ICU isolation ward
| High-touch areas and floors in patient
| 93 | No | Surfaces cleaned/disinfected twice daily.
|
|
| Non-healthcare settings in
| Accommodation rooms, toilets and
| 428 | No | All samples were taken after the infected
|
|
| Wuhan Hospital, China
| Beeper, keyboard, computer mouse,
| 200 | No | All samples were collected around
|
|
| Zhongnan Medical Center
| Major hospital function zones, hospital
| 626 | No | Three sets of surface samples were
|
|
| Hospital in Wuhan, China
| High-frequency contacted surfaces in the
| 38 | No | Samples collected 4 hours after morning
|
|
| Hospital in Singapore | Bedding; the cot rail; a table situated 1
| 6 | No | Infant with COVID-19. 1 HCW. Ct values
|
|
| Hospital outdoor
| Entrance, outdoor toilet, background, in-
| 13 | No | |
|
| Hospital in London, UK
| Bedrails, BP monitors, ward telephones,
| 218 | Yes | Sampling was conducted during three
|
|
| Hospital in Wuhan, China | Nosocomial surfaces, medical touching
| 318 | No | |
|
| Virology Laboratory, Israel
| Door knobs, the outer surface of all
| 6 | No |
Systematic review characteristics.
| Study ID | Objective | Databases
| Search
| Assessment
| No. of
| Main results | Key conclusions |
|---|---|---|---|---|---|---|---|
|
| To assess the
|
| 22/01/2020
| Not reported | 35 | No study assessed viral infectivity or
| There is an inability to align SARS-CoV-2
|
Quality of included studies.
| Study | Description of
| Sample
| Analysis &
| Is bias
| Applicability |
|---|---|---|---|---|---|
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | No | Yes |
|
| Unclear | Yes | Unclear | No | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | No | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| No | Yes | Yes | Unclear | Yes |
|
| Unclear | Unclear | Unclear | Unclear | Unclear |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| Yes | Yes | No | No | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Unclear | Yes | No | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Unclear | No | Yes |
|
| Unclear | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Unclear | No | Unclear |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| No | Unclear | No | No | Unclear |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Yes | No | Yes |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | No | Yes |
|
| Unclear | Unclear | Unclear | Unclear | Unclear |
|
| Yes | Yes | Unclear | No | Yes |
|
| No | Unclear | Yes | No | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Unclear | Unclear | Yes |
|
| Yes | Yes | Yes | No | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Unclear | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| No | Unclear | Unclear | No | Unclear |
|
| Unclear | Unclear | Yes | Unclear | Yes |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Unclear | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | No | Yes |
|
| Unclear | Unclear | Unclear | Unclear | Unclear |
|
| Yes | Yes | Yes | Unclear | Yes |
|
| Unclear | Yes | Yes | Unclear | Yes |
|
| Yes | Yes | Yes | Unclear | Yes |
| 30 | 55 | 40 | 0 | 57 | |
| 63 | 63 | 63 | 63 | 63 | |
| Yes | No/
| ||||
|
| 47.6% | 52.4% | |||
|
| 87.3% | 12.7% | |||
|
| 63.5% | 36.5% | |||
|
| 0.0% | 100.0% | |||
|
| 90.5% | 9.5% |
Figure 2. Risk of bias (n=63 primary studies).
Studies sample collection characteristics.
| Study ID | Frequency of
| Timing of sample collection |
|---|---|---|
|
| Not specified | Not specified |
|
| NA | N/A |
|
| Twice | Unspecified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Once | Before daily disinfection |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Once | After disinfection |
|
| Not specified | After disinfection |
|
| Twice | After disinfection |
|
| Not specified | Before disinfection |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| 1 to 3 times | Not specified |
|
| Not specified | Not specified |
|
| Twice: Pilot phase
| N/A |
|
| Not specified | Not specified |
|
| 3 times | 4 h after case confirmation |
|
| Not specified | 4 h after disinfection |
|
| Not specified | Not specified |
|
| Not specified | Before disinfection |
|
| Not specified | 2 h after disinfection |
|
| Not specified | Not specified |
|
| Not specified | After disinfection (hospital)
|
|
| Twice | Before disinfection |
|
| N/A | N/A |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| End of work shift | Before disinfection |
|
| Not specified | Not specified |
|
| Not specified | After disinfection |
|
| Not specified | Not specified |
|
| 5 separate time
| Before disinfection |
|
| 5 days over a
| Before and after (33.3%:66.7%) |
|
| Not specified | Not specified |
|
| Once | After disinfection |
|
| Not specified | Not specified |
|
| Not specified | Before disinfection |
|
| Not specified | Before disinfection |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Twice daily | After disinfection (4 days) |
|
| Not specified | Before disinfection |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Before disinfection |
|
| Not specified | After disinfection |
|
| Not specified | Before disinfection |
|
| Not specified | Before and after (50%:50%) |
|
| Not specified | Before disinfection |
|
| Three sets over a
| Not specified |
|
| Not specified | After disinfection |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Not specified |
|
| Not specified | Before disinfection |
Findings of included studies.
| Study ID | Frequency of COVID-19 positive
| Concentration of
| Cycle Threshold | Viral culture | Notes |
|---|---|---|---|---|---|
|
| 17/101 (16.8%) | 70-2990 genomic
| Not reported | Not performed | Viral load was highest in the hospital front
|
|
| 31/425 (7.3%) | Not reported | CT values increased
| Not performed | Banknotes sampled from the ticket vendors
|
|
| Tap handle 68.8%
| 25.9 to 132.69
| Not reported | Not performed | Viral load was consistently lower with RNA
|
|
| 4/22 (18.2%) | Not reported | 33.75 to 38.80 | Not performed | qRT-PCR is unable to differentiate between
|
|
|
| Not reported | 34 to 37.9 | None of the samples
| On viral-contaminated plastic coupons, titres
|
|
| 1/13 (7.7%) | 6.5 × 10
2 copies/
| Not reported | Not performed | |
|
| 19/377 (5%) | 1.1 × 10
2 to 9.4 ×
| Not reported | Not performed | The contamination rate was highest on
|
|
| Floor: 65%
| Not reported | 28.45–35.66 | Not performed | High touch surface contamination occurred
|
|
| 0/16 (0%) | Not reported | Not reported | Not performed | |
|
| 2/26 (7.8%) | Not reported | Not reported | None of the inoculated
| |
|
| Inside patients’ rooms: 3/22 (13.6%)
| Not reported | 29.54 to >35 | Not performed | All samples tested positive for IC control,
|
|
| 0/24 (0%) | Not reported | Not reported | Not performed | |
|
| 7/107 (6.5%) | 407 to 723 RNA
| 36.1 to 37.9 | Not performed | Positive samples were from inside door handle
|
|
| 4/152 (3.4 %) | Not reported | Not reported | No infectious virus could
| No correlation between PCR-positive
|
|
| 0/237 (0%) | Not reported | Not reported | Not performed | |
|
| Private surfaces: 4/132 (3%)
| Not reported | Not reported | Could not perform viral
| |
|
| 7/55 (12.7%) | Not reported | 36.05 to 41.06 | Not performed | |
|
| 16/112 (14.3%) | Not reported | Not reported | Not performed | 15/16 of positive samples were from ICU. |
|
|
| ICU Contaminated
| Not reported | Not performed | The rate of positivity was higher for surfaces
|
|
| 29/348 (8.3%) | Majority of our
| Not reported | Not performed | The estimated risk of infection from touching
|
|
| 5/24 (20.8%) | Viral RNA ranged
| Not reported | Not performed | |
|
| 1st batch: 11/23 (47.8%)
| Not reported | 26 to 39 | Not performed | 70% of samples taken from the bedroom
|
|
| COVID-19 patient room: 11/26
| Not reported | Not reported | Not performed | |
|
| 1/130 (0.8%) | Not reported | Not reported | Not performed | |
|
| 8/22 (36%) | Not reported | 28.75 to 37.59 | Not performed | All control swab samples were negative for
|
|
| 0/5 (0%) | Not reported | Not reported | Not performed | |
|
| All surfaces: 89/320 (27%)
| Not reported | Ct values varied
| Not performed | |
|
| Hospitals: 0/68 (0%)
| Not reported | 27.4 to 34.8 | Not performed | Note: Hospitals were disinfected. |
|
| 9/182 (5%) | Not reported | Patient's facemask
| Not performed | |
|
| 8/14 (57%) | 3.4 × 10
3 copies/
| Not reported | Not performed | The concentration of SARS-CoV-2 RNA
|
|
| qRT-PCR: 0%; ddPCR: 13/61 (21.3%) | From 0.84
| Not reported | Not performed | |
|
| All surfaces: 13/242 (5.4%)
| Not reported | 36.38 ± 1.92 | Not performed | |
| 13/242 (5.4%) | 33.5 to 39.54 | Not performed | |||
|
| 12/26 (46.2%) | 20 copies/cm
2 in
| Not reported | Not performed | The highest SARS-CoV-2 RNA signal was
|
|
| Locations with positive employees:
| Not reported | 35 to 38 | Not performed | Locations with positive environmental surfaces
|
|
| 30/336 (8.9%) | 2·2 × 10
5 to 59
| 28·8 to 39·1 | No CPE or a decrease
| |
|
| 4/141 (2.8%) | 2.96 × 10
3 copies/
| Not reported | Not performed | |
|
| All surfaces: 5/89 (5.6%)
| Not reported | 37.38 to 39.18 | Not performed | |
|
| ICU ward common areas: 6/60 (10%)
| Not reported | Not reported | All samples
| Viral cell culture was not attempted on patient
|
|
| Environmental sites: 17/28 (61%)
| Not reported | 30.64 to 38.96 | Not performed | |
|
| 0/90 (0%) | Not reported | 20.8 to 32.23 | Not performed | |
|
| 4/15 (26.7%) | Not reported | 31 to 35 | Not performed | |
|
| 10/192 (5.2%) | Not reported | 35.71 to 39.69 | Because of weak
| |
|
| 0/96 (0%) | Not reported | Not reported | Not performed | |
|
| 9/34 (24.3%) | Not reported | 21.5 to 24 | Not performed | |
|
| Hospital A: 10/57 (17.5%)
| Not reported | Not reported | Not performed | Hospital A (more severe patients in well-
|
|
| All personal items: 70.6%
| Mean
| Not reported | Due to the low
| |
|
| 4/10 (40%) | 3227 ± 3674
| Not reported | Not performed | |
|
| 0/12 (0%) | Not reported | 27.97 to 39.78 | Not performed | |
|
| 58/601 (9.7%) | Not reported | 26.21–38.99 | No virus was cultured | SARS-CoV-2 RNA was detected from about
|
|
| ICU: 2/28 (7.1%)
| Not reported | 37.56 and 39.00 | Not performed | |
|
| 0/45 (0%) | No positive
| No positive
| No positive samples | |
|
| 10/445 (2.2%) | Not reported | 32.69 | Not performed | Of the 4 index cases who required
|
|
| 44/112 (39.3%) | Not reported | Not reported | Not performed | |
|
| 3/93 (3.2%) | Not reported | 17.5 to 32.9 | Not performed | |
|
| Before disinfection: 2/428 (0.5%)
| Not reported | Not reported | Not performed | |
|
| 38/200 (19%) | Not reported | Not reported | Not performed | |
|
| 85/626 (13.6%) | Not reported | Not reported | Not performed | The most contaminated objects were self-
|
|
| 0/38 (0%) | Not reported | Not reported | Not performed | |
|
| Environmental sites: 3/3 (100%)
| Not reported | 28.7, 33.3, and 29.7 | Not performed | |
|
| 0/13 (0%) | Not reported | Not reported | Not performed | |
|
| 23/218 (10.6%) | 10
1 to 10
4 genome
| >30. | No virus was cultured | Viral RNA was detected on 114/218 (52.3%) of
|
|
| 10/318 (3.1%) | 3–8 viruses/cm 2 | Not reported | Not performed | |
|
| 0/6 (0%) | Not reported | Not reported | Not performed |
Figure 3. Rates of positive SARS-Cov-2 tests in studies assessing fomite transmission.
Findings of included studies: viral culture.
| Study ID | Threshold
| Timing of viral
| Method used for viral culture | Cycle
| Results of viral culture |
|---|---|---|---|---|---|
|
| Not specified | Not specified | Applied 200 μL from 10-fold serial sample dilutions upon VERO E6 cell cultures
| 34 to 37.9 | None of the samples
|
|
| All 26
| Not specified | A 200-μL sample was inoculated onto a Vero E6 confluent 24-well microplate
| Not reported | None of the inoculated
|
|
| Not specified | Not specified | Seeded Vero E6 cells in 24 well plates or T25 flasks at a density of 70–80 %. Cells
| Not reported | No infectious virus could
|
|
| Not specified | Not specified | Not reported | Not reported | Could not perform viral
|
|
| <34 | Not specified | Vero E6 cells (Vero C1008; ATCC CRL-1586) in culture medium [MEM
| 28·8 to 39·1 | No CPE or a decrease
|
|
| Positive
| Not specified | Monolayers of Vero C1008 cells (ATCC-1586) in T25 flasks were inoculated
| Not reported | All samples in common
|
|
| Not specified | Not specified | Not specified | 35.71 to
| Because of weak amounts
|
|
| Subset of
| Days 5–9 of patient
| Vero E6 cells. Several indicators were utilized to determine viral replication
| Not reported | Cultivation of virus on cell
|
|
| Some
| No details provided
| Samples were mixed with Dulbecco’s modified Eagle medium supplemented with
| 26.21-38.99 | No virus was cultured |
|
| Not specified | Not specified | Samples were obtained and inoculated on Vero-E6 cells for virus culture. The
| No positive
| No positive samples |
|
| Ct value <30 | Not specified | Vero E6 and Caco2 cells were used to culture virus. The cells were cultured
| >30. | No virus was cultured |
|
|
|
|
|
|
1World Health Organization. Q&A: How is COVID-19 transmitted? https://www.who.int/vietnam/news/detail/14-07-2020-q-a-how-is-covid-19-transmitted
2 https://www.cebm.net/covid-19/sars-cov-2-viral-load-and-the-severity-of-covid-19/
3 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521909/